Vista Pharmaceuticals Ltd () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Checkpoint Trend

Phaarmasia

Murae Organisor

JFL Life

Biofil Chemicals

Godavari Drugs

Lasa Supergeneri

Vista Pharma.

Bacil Pharma

Dipna Pharmachem

Guj. Inject(Ker)

Why is Vista Pharmaceuticals Ltd ?

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Operating profit has grown by an annual rate -15.33% of over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -4.28

Negative results in Sep 25

OPERATING CF(Y) Lowest at Rs -6.98 Cr
PBT LESS OI(Q) At Rs -3.81 cr has Fallen at -155.7% (vs previous 4Q average)
PAT(Q) At Rs -2.59 cr has Fallen at -103.9% (vs previous 4Q average)

Risky - Negative EBITDA

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -25.02%, its profits have fallen by -98.8%

Below par performance in long term as well as near term

Along with generating -25.02% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Vista Pharma. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Vista Pharma.

-25.19%

-0.48

52.00%

Sensex

4.48%

0.38

11.83%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

1.98%

EBIT Growth (5y)

-15.33%

EBIT to Interest (avg)

-4.28

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.19

Sales to Capital Employed (avg)

0.16

Tax Ratio

15.95%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.02%

ROCE (avg)

-9.73%

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.20

EV to EBIT

-8.00

EV to EBITDA

-8.86

EV to Capital Employed

1.17

EV to Sales

7.05

PEG Ratio

Dividend Yield

ROCE (Latest)

-14.58%

ROE (Latest)

-15.01%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-12What is not working for the Company

OPERATING CF(Y)

Lowest at Rs -6.98 Cr

PBT LESS OI(Q)

At Rs -3.81 cr has Fallen at -155.7% (vs previous 4Q average

PAT(Q)

At Rs -2.59 cr has Fallen at -103.9% (vs previous 4Q average

PBDIT(Q)

Lowest at Rs -3.44 cr.

EPS(Q)

Lowest at Rs -0.42

Loading Valuation Snapshot...

Here's what is not working for Vista Pharma.

Profit Before Tax less Other Income (PBT) - Quarterly

At Rs -3.81 cr has Fallen at -155.7% (vs previous 4Q average)

over average PBT of the previous four quarters of Rs -1.49 Cr

MOJO Watch

Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly

At Rs -2.59 cr has Fallen at -103.9% (vs previous 4Q average)

over average PAT of the previous four quarters of Rs -1.27 Cr

MOJO Watch

Near term PAT trend is very negative

PAT (Rs Cr)

Operating Cash Flow - Annually

Lowest at Rs -6.98 Cr and Fallen

each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (Rs Cr)

Operating Profit (PBDIT) - Quarterly

Lowest at Rs -3.44 cr.

in the last five quarters

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly

Lowest at Rs -3.81 cr.

in the last five quarters

MOJO Watch

Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Earnings per Share (EPS) - Quarterly

Lowest at Rs -0.42

in the last five quarters

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (Rs)